Wa Leng Zi
Arca subcrenata Lischke, Arca granosa Linnaeus, Arca inflata Reeve
Also known as: Ark shell(English) 瓦楞子(Chinese)
Wareungja瓦楞子 와릉자 Wa Lêng Tzŭ
Updated October 23, 2026 · Not yet clinically reviewed
Safety at a glance
7 recorded drug interactions, 3 major or contraindicated
Contraindications or side effects are listed
No toxicity grade is recorded. Most herbs in the catalogue carry none.
Traditional Chinese Medicine
- Category
- transforming phlegm
- Temperature
- Neutral
- Taste
- Salty,Sweet
- Channels
- Lung,Stomach,Liver
Functions
Resolves Phlegm and transforms stasis; Dissipates Nodules and Softens Hardness; Controls Acidity and Stops Pain; Invigorates Blood and disperses accumulations
Traditional uses
Wa Leng Zi (cockle shell, blood clam shell) is a neutral, salty substance used in Chinese medicine to dissolve Phlegm and soften hardened masses from Phlegm accumulation — including goiter, scrofula, and thyroid nodules. In its calcined form, its astringent properties become prominent, making it useful for stopping acid reflux, stomachache from hyperacidity, and certain types of bleeding. Its dual role as a Phlegm-dissolving and astringent substance makes it applicable to a range of conditions depending on its preparation.
Formulas using this herb
Botanical
Wa Leng Zi consists of the calcified bivalve shells of several species of ark clams in the family Arcidae, principally Arca subcrenata, Arca granosa (Tegillarca granosa), and Arca inflata, harvested from intertidal mudflats and shallow coastal waters of the western Pacific. The shells are thick, roughly oval to subquadrate, strongly inflated, and externally marked by numerous prominent radial ribs crossed by concentric growth lines, giving them a distinctly ridged, sculptural appearance; the hinge is straight with many small teeth. Externally they are dirty white to grayish or brownish, with remnants of a coarse periostracum, and internally porcellanous white. For medicinal use the shells are cleaned, dried, and calcined, then crushed to a coarse or fine powder consisting primarily of calcium carbonate.
- Family
- Arcidae
- Pharmaceutical name
- Concha Arcae
Constituents
Calcium carbonate
Inorganic carbonate salt · over 95% of the shell by mass; present as aragonite in the raw drug and converted to calcite on calcination
This is effectively the whole drug. Its clinical actions of controlling acidity and stopping pain are the actions of an antacid, and its interaction profile is the interaction profile of calcium carbonate. Calcination converts aragonite to the more stable calcite and measurably increases how much calcium carbonate dissolves into the decoction, which is why the calcined form is the one used for hyperacidity.
Shell matrix protein
Protein (organic shell matrix) · roughly 5% of the raw shell; markedly reduced by calcination
The organic fraction that binds the mineral. It is the main compositional difference between the raw and calcined drug and is largely destroyed by calcination, so any activity attributed to it applies only to the uncalcined shell.
Sodium, strontium and other trace elements
Inorganic trace elements · calcium is highest, followed by sodium and strontium; levels of calcium, sodium and phosphorus rise after calcination
Principal component analysis of the inorganic elements distinguishes Arcae concha from the similar shell drug Meretricis/Cyclinae concha, and the authors suggest the differing trace-element profile is what separates their therapeutic emphases. No pharmacological effect has been demonstrated for these elements at the doses supplied by the drug.
Drug interactions
Tetracyclines and fluoroquinolones (e.g. doxycycline, ciprofloxacin, levofloxacin)
Major · Substantially reduced antibiotic absorption and possible treatment failure · Evidence level: Established
The drug is over 95% calcium carbonate. Divalent calcium chelates tetracyclines and fluoroquinolones in the gut lumen to form poorly absorbed complexes; this is a well-established, clinically significant interaction for any calcium-containing antacid and applies directly to Concha Arcae, which is dosed in grams.
Clinical note: Separate the herb from the antibiotic by at least 2 hours before or 4 to 6 hours after the dose, or suspend the herb for the antibiotic course.
Levothyroxine
Major · Reduced levothyroxine absorption and loss of thyroid control · Evidence level: Established
Calcium carbonate binds levothyroxine in the gastrointestinal tract and reduces its absorption; this is a documented cause of rising TSH in patients stabilised on replacement. A gram-dose calcium carbonate herb taken with breakfast sits exactly where levothyroxine is normally taken.
Clinical note: Separate by at least 4 hours. Check TSH about 6 to 8 weeks after starting or stopping the herb in a patient on replacement.
Oral bisphosphonates (e.g. alendronate, risedronate)
Major · Near-complete loss of bisphosphonate absorption · Evidence level: Established
Oral bisphosphonates have very low bioavailability and are chelated by calcium; the product labels require dosing with plain water and no calcium-containing product for at least 30 to 60 minutes afterwards. Concha Arcae is a calcium carbonate preparation and falls squarely under that restriction.
Clinical note: Give the bisphosphonate on waking with water and keep the herb to later in the day.
Oral iron salts (e.g. ferrous sulfate)
Moderate · Reduced iron absorption · Evidence level: Established
Calcium reduces the absorption of both haem and non-haem iron, and raising gastric pH further reduces the solubility of ferrous salts. Both mechanisms apply to a gram-dose calcium carbonate shell drug.
Clinical note: Separate iron from the herb by at least 2 hours. This matters most in the patient being treated for iron-deficiency anaemia caused by the upper gastrointestinal bleeding the herb is often prescribed alongside.
Drugs needing gastric acid for absorption (e.g. atazanavir, ketoconazole, itraconazole capsules)
Moderate · Reduced absorption and possible loss of efficacy · Evidence level: Probable
Neutralising gastric acid is the intended action of this drug, and the same acid is required to dissolve weakly basic drugs such as the azole antifungals and atazanavir. Antacid co-administration is a recognised cause of subtherapeutic levels of these agents.
Clinical note: Separate by at least 2 hours, and prefer an alternative acid-suppressing strategy if the patient depends on one of these drugs.
Thiazide diuretics and high-dose vitamin D
Moderate · Hypercalcaemia, and at high sustained intake milk-alkali syndrome · Evidence level: Probable
Thiazides reduce renal calcium excretion and vitamin D increases calcium absorption. Adding a gram-dose absorbable calcium carbonate on top of either is the classic setting for hypercalcaemia, and prolonged high intake of calcium carbonate with alkali is the recognised cause of milk-alkali (calcium-alkali) syndrome with hypercalcaemia, metabolic alkalosis and renal impairment.
Clinical note: Avoid prolonged high-dose use with thiazides or vitamin D supplements. Check serum calcium and creatinine if the herb is used at antacid doses for more than a few weeks.
Concha Meretricis seu Cyclinae (Hai Ge Ke) and Concha Ostreae (Mu Li) as substituted drugs
Minor · A different shell drug dispensed under the same indication · Evidence level: Probable
Arcae concha and Meretricis/Cyclinae concha are described in the analytical literature as marine shell drugs of similar composition and efficacy that are routinely calcined and used clinically, and their inorganic profiles overlap enough that qualitative identification is difficult once the shells are broken or powdered. Trace-element profiling separates them, but a practitioner receiving powdered material cannot. The therapeutic consequence is modest because the calcium carbonate action is shared, but the traditional indications differ.
Clinical note: Buy the drug as recognisable ribbed valves rather than as powder if the distinction matters to the prescription.
Dosage
| Form | Amount | Frequency | Notes |
|---|---|---|---|
| decoction (pre-decocted) | 9–15 g | Daily | 中国药典 2020 【用法与用量】9~15g,先煎。 【性味与归经】咸,平。归肺、胃、肝经。 — Chinese Pharmacopoeia 2020, quoted verbatim; route and cautions preserved. Replaces a cleared category-filler value. |
Dui yao: classical pairings
Wa Leng Zi + Hai Fu Shi海浮石
Both soften hardness and dissipate phlegm nodules; together they reduce stubborn phlegm accumulations.
Named pairing — Lü Jingshan, Shi Jinmo Dui Yao
Evidence
Study design on record, not certainty of outcome.
- In vitro / animal
- 3
Structural and Compositional Changes in Two Marine Shell Traditional Chinese Medicines: A Comparative Analysis Pre- and Post-Calcination
Wu L, Liu C, Yao T, Shi Y, Shen J, Gao X, Qin K · Journal of AOAC International · 2024 · in vitro
In vitro / animal · Verified
Infrared, X-ray and X-ray fluorescence spectroscopy, thermogravimetry and BCA protein assay applied to Arcae concha and Meretricis/Cyclinae concha from several production regions. Calcium carbonate in the raw shells was aragonite and converted to calcite on calcination; protein content fell markedly; calcium, sodium and strontium were the dominant inorganic elements; and calcium carbonate dissolution into the decoction increased after calcination, which supports the traditional preference for the calcined form. Production region made no significant difference, and the authors conclude that composition alone cannot reliably identify these drugs.
Antitumor Effect of a Polypeptide Fraction from Arca subcrenata in Vitro and in Vivo
Hu X, Song L, Huang L, Zheng Q, Yu R · Marine Drugs · 2012 · animal
In vitro / animal · Not yet verified
A polypeptide fraction P2 inhibited proliferation of seven tumour cell lines, with IC50 of 11.43 micrograms/mL in HeLa and 13.00 micrograms/mL in HT-29 at 48 h, had little cytotoxicity to L-02 normal liver cells, and inhibited H-22 and S-180 tumour growth in mice by up to 46.4% and 60.1%. Important caveat for this record: P2 was extracted from the soft body of the clam, not from Concha Arcae. Wa Leng Zi is the shell, which is over 95% calcium carbonate and contains no such polypeptide fraction, so this study does not support any antitumour claim for the shell drug.
Identification and Characterization of a Novel Protein ASP-3 Purified from Arca subcrenata and Its Antitumor Mechanism
Guo Z, Shi H, Li C, Luo Y, Bi S, Yu R, Wang H, Liu W, Zhu J, Huang W, Song L · Marine Drugs · 2019 · in vitro
In vitro / animal · Not yet verified
ASP-3, a 179-residue 20.6 kDa protein identified as a sarcoplasmic calcium-binding protein, inhibited HepG2 proliferation with IC50 171.18 plus or minus 18.59 micrograms/mL and interacted directly with VEGFR2, reducing its phosphorylation and blocking VEGF-induced tube formation. That the protein is sarcoplasmic makes its origin explicit: it comes from the clam's muscle, not from the shell. As with the polypeptide work, it is evidence about Arca subcrenata as an organism and not about the drug Concha Arcae.
Safety
Contraindications
It is not suitable for patients without static blood and phlegm accumulation.
Source: Xi S, Gong Y. Essentials of Chinese Materia Medica and Medical Formulas. Academic Press/Elsevier, 2017, pp. 267–277.
Cultural and historical
Ming Yi Bie Lu · Southern and Northern dynasties
Ri Hua Zi Ben Cao · Five Dynasties
Ben Cao Gang Mu · Ming dynasty
References
- Wu L, Liu C, Yao T, Shi Y, Shen J, Gao X, Qin K. Structural and Compositional Changes in Two Marine Shell Traditional Chinese Medicines: A Comparative Analysis Pre- and Post-Calcination. Journal of AOAC International. 2024 doi:10.1093/jaoacint/qsae023
- Song L, Ren S, Yu R, Yan C, Li T, Zhao Y. Purification, Characterization and in vitro Anti-Tumor Activity of Proteins from Arca subcrenata Lischke. Marine Drugs. 2008 doi:10.3390/md6030418